Table 4.
World population coverage of the selected T-cell epitopes
| Population | Coverage a | Average Hit b | pc90 c |
|---|---|---|---|
| Central Africa | 73.21 | 1.08 | 0.37 |
| Central America | 2.98 | 0.03 | 0.1 |
| East Africa | 73.16 | 1.05 | 0.37 |
| East Asia | 94.63 | 1.77 | 1.14 |
| Europe | 92.69 | 1.65 | 1.07 |
| North Africa | 80.71 | 1.26 | 0.52 |
| North America | 91.79 | 1.63 | 1.05 |
| Northeast Asia | 87.81 | 1.33 | 0.82 |
| Oceania | 87.78 | 1.22 | 0.82 |
| South Africa | 71.61 | 0.99 | 0.35 |
| South America | 82.94 | 1.22 | 0.59 |
| South Asia | 81.02 | 1.19 | 0.53 |
| Southeast Asia | 87.46 | 1.28 | 0.8 |
| Southwest Asia | 79.39 | 1.2 | 0.49 |
| West Africa | 78.87 | 1.24 | 0.47 |
| West Indies | 88.68 | 1.55 | 0.88 |
| World | 90.04 | 1.51 | 1 |
| Mean±SD | 79.10± 20.24 | 1.25±0.37 | 0.67±0.29 |
Projected population coverage
Average number of epitope hits/human leukocyte antigencombinations recognized by the population
Minimum number of epitope hits/human leukocyte antigencombinations recognized by 90% of the population